Exploring the Regulatory Terrain of Drug Advertising on Social Networks: Methods and Challenges
Germany's online pharmaceutical marketing landscape, particularly for prescription medicines, is governed by stringent regulations. These rules extend to influencer marketing, often referred to as "med-influencer" marketing, despite the term not being formally defined in legislation.
The Legal Landscape
Prescription Medicines
- Direct-to-consumer advertising for prescription medicines is prohibited in Germany, in accordance with European Union law.
- Influencer marketing involving prescription medicines is de facto subject to the same restrictions as traditional advertising. Any promotion of prescription drugs to the general public—including via social media or influencers—is illegal.
The core principles are enshrined in Section 7(1) HWG (Heilmittelwerbegesetz), which explicitly prohibits advertising prescription medicines to the general public, and Section 10 HWG, which sets further requirements for advertising medical products.
Non-Prescription Medicines
- Advertising for over-the-counter (OTC) medicines is allowed but must comply with strict honesty and accuracy requirements.
- Influencer marketing for OTC products is legally grey. If the influencer is seen as promoting a product without clear disclosure, it may violate transparency and fair competition laws.
- Financial incentives for purchasing even OTC medicines—such as vouchers or discounts—are prohibited if they are product-related and influence purchasing decisions.
- Product-related advertising is strictly regulated. Even general marketing of a pharmacy’s product range can be considered product-related under the HWG.
Influencer-Specific Considerations
- Transparency: Influencers must clearly disclose any commercial relationship with the brand or pharmacy, as required by general consumer law.
- No Health Claims: Influencers cannot make therapeutic or medical claims about efficacy unless these are scientifically proven and authorized, which is rare for new or unapproved products.
- Personal Data: Influencers and brands must comply with the General Data Protection Regulation (GDPR) when collecting or processing personal health data from their audience.
- Professional Boundaries: German practice and law draw a clear line between professional medical advice (e.g., from doctors or pharmacists) and commercial promotion. Influencers who are not healthcare professionals may not give advice on medicines, especially prescription-only.
Recent Case Law and Regulatory Action
- Frankfurt Higher Regional Court (OLG Frankfurt): Recently reaffirmed that promotional vouchers for online pharmacies, even those for OTC medicines, violate the prohibition on benefits under Section 7(1) HWG if they influence purchasing decisions.
- No “Low-Value” Exception: The court clarified that even small financial incentives (e.g., €10 vouchers) are not exempt, as the typical threshold for “low-value items” is set at €1.
- Pharmacies: Both online and offline pharmacies must ensure their marketing, including any influencer partnerships, complies with HWG and related court decisions.
Enforcement and Penalties
- Regulatory Authorities: The Federal Institute for Drugs and Medical Devices (BfArM) and local authorities enforce HWG violations.
- Penalties: Infringements can result in fines, injunctions, and reputational damage.
- Self-Regulation: The German Advertising Council (Deutscher Werberat) may also intervene in influencer cases, though its rulings are non-binding.
Key Takeaway
Influencer marketing for pharmaceuticals in Germany—especially for prescription drugs—faces very strict legal limits. While OTC products may be advertised with certain restrictions, financial incentives are largely off-limits, and transparency is mandatory. All marketing must comply with the HWG and related case law, with no exceptions for new digital or social media formats. Brands and influencers must be especially cautious not to blur the lines between professional medical advice and commercial promotion.
Adhering to advertising regulations, ensuring transparency, and monitoring user-generated content should be essential elements of any company's social media strategy. Pharmaceutical companies should establish clear internal guidelines and policies to manage social media interactions and understand the legal implications of their actions online. Pharmaceutical companies and other life sciences and healthcare industry players use social media for marketing, and they must monitor their digital platforms for adverse drug reactions and report them as required by pharmacovigilance regulations. Advertisements must include mandatory information such as approved uses and potential side effects. Off-label advertising, which markets a product for uses other than its approved indications, is prohibited. Social media is widely used for health-related information by consumers globally.
- The rules governing science-based health-and-wellness promotion in Germany, particularly through influencer marketing, are as stringent as those for prescription medicines due to the de facto extension of the same restrictions to influencer marketing.
- Influencer-led health-and-wellness promotions in Germany, even for over-the-counter products, must adhere to strict regulations, including transparency, avoidance of health claims, compliance with data protection laws, and professional boundaries, to prevent violations of advertising and competition laws.
